MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1007/978-981-13-9151-4_6

Медицинская библиотека · Advances in experimental medicine and biology · 2020

Present and Future Therapies for Chronic Hepatitis B.

Tao Yachao, Wu Dongbo, Zhou Lingyun, Chen Enqiang, Liu Changhai, Tang Xiaoqiong, Jiang Wei, Han Ning, Li Hong, Tang Hong

СтатьяОбзорПеревод в очереди

Аннотация

Chronic hepatitis B (CHB) remains the leading cause of liver-related morbidity and mortality across the world. If left untreated, approximately one-third of these patients will progress to severe end-stage liver diseases including liver failure, cirrhosis, and hepatocellular carcinoma (HCC). High level of serum HBV DNA is strongly associated with the development of liver failure, cirrhosis, and HCC. Therefore, antiviral therapy is crucial for the clinical management of CHB. Current antiviral drugs including nucleoside/nucleotide analogues (NAs) and interferon-α (IFN-α) can suppress HBV replication and reduce the progression of liver disease, thus improving the long-term outcomes of CHB patients. This chapter will discuss the standard and optimization antiviral therapies in treatment-naïve and treatment-experienced patients, as well as in the special populations. The up-to-date advances in the development of new anti-HBV agents will be also discussed. With the combination of the current antiviral drugs and the newly developed antiviral agents targeting the different steps of the viral life cycle or the newly developed agents modulating the host immune responses, the ultimate eradication of HBV will be achieved in the future.

Для цитирования: Tao Yachao, Wu Dongbo, Zhou Lingyun, Chen Enqiang, Liu Changhai, Tang Xiaoqiong, Jiang Wei, Han Ning, Li Hong, Tang Hong. Present and Future Therapies for Chronic Hepatitis B.. Advances in experimental medicine and biology. 2020. DOI: 10.1007/978-981-13-9151-4_6.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.